Forest to pay US$2.9 billion for Aptalis

14 January 2014 - Deborah Wilkes

Archived

Forest Laboratories is set to acquire privately-held speciality pharmaceutical company Aptalis for US$2.9 billion in cash.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: